Class IX myosins are unique among the many classes of known actin-based motors in that the tail region of these myosins contains a GTPase-activating protein domain for the small GTP-binding protein, Rho. Previous studies on human myosin-IXb indicate that this myosin is mechanochemically active and exhibits actin-binding properties similar to the processive motor, myosin-Va. Motility analysis of antibody-tethered myosin-IXb performed using the sliding actin filament assay indicates that this myosin does exhibit properties characteristic of a processive motor. Like myosin-Va, the velocity of myosin-IXb remains constant (38.2 ؎ 1.2 nm/s) even at single motor/filament densities. At low motor densities, filaments can be seen passing through and pivoting about single points on the motility surface. Analysis of filament landing rates as a function of motor density also indicates that a single motor is sufficient for filament movement. However, in contrast to myosin-Va, which uses coordinated motion of its two heads to move processively along the filament, hydrodynamic and chemical cross-linking studies indicate that under the conditions tested, myosin-IXb is a single-headed motor consisting of a single heavy chain and associated light chains.
Class IX myosins contain a number of unique features in comparison to the other classes of myosins characterized thus far. Class IX myosin have been identified in both vertebrate and invertebrate species (1, 2) . The most extensively characterized class IX myosins include the two myosins IX in rat (Myr 5 and Myr 7 (3, 4) and human (myosin-IXb (Myo9b) and myosin-IXa (4 -6)). Both class IX myosins have similar overall domain structure, although they exhibit distinct tissue expression patterns (1) . The hallmark structural feature of these myosins with respect to their function is within the tail domain: a GTPase-activating protein (GAP) 1 domain structurally homologous to GAPs for the Rho family of G proteins. Biochemical characterizations of both bacterially expressed Myr 5 and Myr 7 tail domains and tissue-purified human Myo9b demonstrate that these myosins IX are active GAPs for Rho but not Rac or CDC 42 (3, 4, 7) . Moreover, overexpression of both Myr 5 and Myr 7 in cultured cells results in inactivation of Rho in these cells (4, 8) . Thus, unlike proposed cargo-carrying functions for most other myosins, class IX myosins may be their own cargo, with the motor domain carrying its Rho-GAP tail to sites that require down-regulation of Rho-dependent signaling (1, 9) .
The motor domain of class IX myosins also contains distinctive features compared with other myosins. This includes an N-terminal extension that is structurally homologous to a Ras binding domain, although expressed fusion protein containing this domain from Myr 5 lacks Ras binding activity (10) . Relative to other myosins, the motor domain also contains a large (ϳ140 amino acids in Myo9b) highly basic insertion at the presumed site of actin contact (referred to as surface loop two in the atomic structure of the motor domain of myosin-II (11)). Between the motor and tail domain is a neck domain consisting of four IQ light chain-binding motifs. At least a subset of human Myo9b light chains is calmodulin (CaM) (7) . Despite the unusual structure of the motor domain, motility chambers containing antibody-tethered human Myo9b exhibit robust, albeit slow (ϳ15 nm/s), gliding actin filament movements in vitro (7) . Velocities are reduced in the presence of Ca 2ϩ , as has been observed for a number of CaM-containing myosins (reviewed in Refs. 12 and 13). Myo9b does exhibit unusual actin-binding properties, in that this myosin co-sediments with actin in presence of ATP (7), a property it shares with myosin-Va (14, 15) . Interestingly, high affinity binding to actin at steady state in the presence of ATP is thought to contribute to the unique motile properties of myosin-Va where biophysical studies have shown that this motor is capable of undergoing numerous interactions with an actin filament before diffusing away. Thus, myosin-Va is classified as a highly "processive" motor (16) . However, unlike myosin-Va, which is thought to generate processive motion through a coordinated interaction of two motor domains (16 -18) , the heavy chain of class IX myosins lacks coiled-coil forming ␣-helical segments and thus is predicted to be single-headed.
In the present study we have further characterized the physical and mechanochemical properties of human Myo9b. Determination of the native molecular weight (M r ) indicates that this myosin is indeed single-headed. Moreover, an assessment of the motor properties of Myo9b as a function of motor surface density in the gliding actin filament assay indicates that like myosin-Va, Myo9b exhibits properties of a high duty ratio, processive actin-based motor.
EXPERIMENTAL PROCEDURES
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§ Both authors contributed equally to this work. imum speed) with a handheld Omni Mixer micro-homogenizer (Omni International, Gainesville, VA) in Buffer A (25 mM HEPES, 0.6 M NaCl, 5 mM MgCl 2 , 5 mM EGTA-Na, 5 mM ATP, 2 mM dithiothreitol, 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride, 6.25 g/ml leupeptin, 12.5 g/ml pepstatin (all reagents from Sigma). The resulting homogenate was centrifuged at 227,000 ϫ g for 30 min. The supernatant (175 l) or 175 l of a mixture of protein standards including myoglobin, ovalbumin, bovine serum albumin, aldolase, and catalase (Sigma) was layered onto 4.75-ml linear 6 -20% (w/w) sucrose gradients in Buffer A and centrifuged for 17 h at 38,000 rpm in an SW 55 rotor at 4°C. The elevated salt concentration of this buffer (0.6 M NaCl) was used for both the sucrose gradient and gel filtration (see below) to minimize artifactual molecular weight shifts of Myo9b caused by ATPindependent binding to small F-actin oligomers that may be present in the extract. Fractions of 259 l were collected from the top of the tube. The sedimentation profile of the protein standards was determined by SDS-PAGE and that of Myo9b and myosin-IIa was determined by immunoblot analysis using affinity-purified anti-Myo9b tail (7) and anti-human platelet myosin-IIa (Biomedical Technologies, Stoughton, MA). Blots were developed using the ECL method as recommended by the ECL reagent vendor (Pierce).
The Stokes radius (R S ) of Myo9b was estimated by chromatography of the ultraspeed supernatant fraction described above over a Sephacryl S500 (Amersham Biosciences) gel filtration column equilibrated in Buffer A. The column was calibrated by adding proteins of known R S values to the supernatant. Proteins used included aldolase, catalase, ferritin, thyroglobulin, fibrinogen, and IgM. The included volume of the column was 174.5 ml, and the void volume was 59 ml. Elution profiles of the protein standards and myosins-IXb and -IIa were determined by SDS-PAGE (protein standards) or immunoblot analysis (myosins IXb and myosin-II).
Chemical Cross-linking-Human chronic lymphocytic leukemia cells were homogenized in Buffer A and centrifuged as above. The ultraspeed supernatant was incubated with 50 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (Pierce) or an equivalent volume of Buffer A for 1 h at room temperature. The sizes of cross-linked myosins-IXb and -II were determined by SDS-PAGE immunoblot analysis.
In Vitro Motility-In vitro motility assays using immunopurified Myo9b were performed exactly as described in Post et al. (7) except that a human leukemia cell line (HL60) was used as the purification source. Briefly, motility chambers were coated with Protein A (0.5 mg/ml) and then incubated with anti-Myo9b (see below) and blocked with casein and bovine serum albumin, followed by overnight incubation with chromatographically (Q-Sepharose) enriched fractions of Myo9b. After adsorption of Myo9b, the motility chambers were washed with high salt (750 mM KCl) to remove nonspecifically adsorbed proteins that might interfere with motility and, in the context of the hydrodynamic studies, would also disrupt any salt-sensitive oligomeric complexes containing Myo9b. Thus, these motility assays were performed under conditions in which the Myo9b is presumably single-headed based on the hydrodynamic studies presented here. To determine the dependence of filament gliding velocity as a function of Myo9b motor density, the concentration of Myo9b trapping antibody was varied in the motility chambers from 0 to 200 g/ml. The antibody solution was supplemented with rabbit non-immune IgG to keep the total IgG concentration in the motility chambers constant. The determination of Myo9b surface density at different antibody concentrations was performed using quantitative Western blots as reported previously (20) . Briefly, motility chambers coated with a wide range of anti-tail IgG concentrations were incubated with Myo9b. The unbound protein fractions were then removed and processed for immunoblotting. Blots were developed using the ECL method; films were scanned, and the integrated optical density of each band was quantified using Scion Image (Scion Corp., Frederick, MD). These optical densities were calibrated, using known quantities of bacterially expressed Myo9b tail fusion protein (7) as standards, and represented the unbound quantity of M9 liberated from each chamber. Three independent sets of chambers were quantified in this way. IgG concentration versus molecules of Myo9/m 2 retained in each chamber (i.e.
[input] Ϫ [unbound]) was then plotted, using data from three independent sets of chambers, to determine the range of anti-tail IgG over which Myo9b binding was linear. The slope of the linear region (5.5 g/ml anti-tail IgG/molecule/m 2 ; R 2 ϭ 0.86) was used to calibrate the x axis of the motility plots.
To estimate duty ratio from sliding filament velocities, a modification of the model originally developed by Uyeda et al. (19) was used to generate theoretical curves for fitting velocity data as described previously (20) . Here average filament velocity (V avg ) was expressed as a function of saturation velocity (V max ), duty ratio (f), motor density (), and the mean interaction area for the assay (A , roughly the product of the filament length and twice the reach of the motor) as indicated in Equation 1,
For the purposes of creating the theoretical curves shown in Fig. 3A , different values of f were fixed with V max ϭ 38.4 nm/s (from the best fit to the data) and A ϭ 0.188 m 2 (from the landing rate fit, see below). The frequency of successful filament landing events (i.e. the appearance of an actin filament in the focal plane that then begins to move) as a function of Myo9b motor density was also determined. The results were used to estimate the total number of motor molecules required for filament movement as described by Howard et al. (21) . Landing rates are plotted with errors derived from counting statistics (S.E. ϭ mean landing rate/square root of n, where n ϭ number of filaments observed (22)). To obtain a lower limit for the number of motors required to bind and move a filament, the following model, originally described by Hancock and Howard (22) , was used to fit landing rate data with respect to motor density as indicated in Equation 2,
where L is the landing rate as a function motor density (); Z is the maximum landing rate; A is the area of interaction surrounding a filament (as defined above), and n is the number of motor molecules required for a successful landing event. Values for Z, A , and n from the best fit (three free parameters) were 11.8 s Ϫ1 mm Ϫ2 , A ϭ 0.188 m 2 , and n ϭ 1.01. For the theoretical curves shown in Fig. 3B , n was fixed at either 1 or 2, and A and Z were left as free parameters. As revealed by visual inspection and fit statistics (n ϭ 1, S.E. ϭ 0.74, F statistic ϭ 160; n ϭ 2, S.E. ϭ 0.92, F statistic ϭ 100), the n ϭ 1 curve provided the best fit to the data.
RESULTS

Myosin-IXb Is a Single-headed
Motor-To determine the native molecular weight of human leukocyte Myo9b, hydrodynamic characterization was performed using gel filtration chromatography and sucrose gradient centrifugation (Fig. 1) . The measured Stokes radius (R S ) was 10.2 nm, and the sedimentation coefficient (s 20,w ) was 7.3. R S and s 20,w measurements were repeated at least three times and varied by 4%. These values were used to calculate (23) a native molecular weight for Myo9b of 302,500 (Table I ). This molecular weight is comparable with the calculated value of 303,569 from primary sequence for a single heavy chain (using the average molecular weight of the two splice forms) and four CaM light chains (Myo9b has four IQ motifs and CaM co-immunoprecipitates with the protein (6, 7) ). These results demonstrate that Myo9b is a single-headed motor consisting of a single heavy chain and associated light chains.
Results from chemical cross-linking experiments provide further evidence that Myo9b is single-headed. Human leukocyte extracts enriched for Myo9b were treated with the zero length cross-linker 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (Fig. 2) . Immunoblot analysis of the extract with and without cross-linker demonstrated that some of the cross-linked Myo9b migrates as a smear more slowly through the gel than uncrosslinked Myo9b as would be expected for cross-linking of various CaM light chains to the heavy chain. However, all of the crosslinked Myo9b ran faster than the 340-kDa molecular mass marker (Fig. 2) . This result is consistent with the measured native molecular weight for the molecule of 302,500 (Table I) . Furthermore, cross-linked and presumably dimeric complexes of myosin-IIa present in the leukocyte extract ran much more slowly through the gel than cross-linked Myo9b (Fig. 2) . If Myo9b were cross-linked into a dimer of two heavy chains and up to eight CaM light chains, it would have a molecular mass of ϳ600 kDa (based on its amino acid composition) and would be expected to migrate more slowly through the gel than crosslinked myosin-II dimer (which has a molecular mass of ϳ400 -482 kDa depending on the number of light chains linked to the heavy chain). (7) used a modification of the gliding filament assay, in which Myo9b is immunoadsorbed onto the motility chamber using anti-tail antibodies, to demonstrate that this myosin is an active motor. In the gliding actin filament assay (24) , gliding velocity decreases sharply as a function of surface motor density for non-processive motors such as myosin-II (19) . This can be explained by realizing that these motors are only strongly bound to actin for a small fraction of their total cycle time (attached duration/total cycle duration ϳ0.05), i.e. they possess a low duty ratio. As a result, multiple motors are required to propel a filament at maximal velocity. In contrast, the velocity of the processive actin-based motor chicken myosin-Va is independent of density even at single motor/filament densities (16, 20) , a property first shown for the processive motor kinesin using a gliding microtubule assay (21) . For these motors to be capable of producing continuous, maximal velocity at single motor/filament densities, they must possess a very high duty ratio (ϳ1). Therefore, observing filament gliding velocities as a function of surface motor density can provide insight concerning the cycling kinetics of a molecular motor and its potential to move processively.
Antibody-tethered Myosin-IXb Exhibits Motile Properties Characteristic of a Processive Motor-We have previously
As a means to assess gliding velocities as a function of Myo9b motor density, motility chambers coated with varied concentrations of anti-tail antibodies were analyzed (0 -200 g/ml, keeping total IgG concentration at 200 g/ml with non-immune rabbit IgG). Quantitative immunoblot analysis revealed that the surface density of adsorbed Myo9b increased in a linear fashion from 0.6 to 18.2 molecules/m 2 over a range of antibody dilutions from 0 to 100 g ml, with no further increase in motor concentration above 200 g/ml (Fig. 3A) . As in our previous studies (7) we observed robust gliding movements in chambers that contain Ͼ3 g/ml anti-tail antibody, whereas no movement was observed in chambers containing 0 -3 g/ml tail antibody. Above this concentration a constant average velocity of 38.2 Ϯ 1.2 nm/s (mean across all densities Ϯ S.E.) was observed at all concentrations. The velocity observed in this study is significantly faster than we observed previously (15 nm/s), most likely because freshly harvested, unfrozen HL-60 cells rather than frozen human leukocyte cell pellets were used to generate the partially purified fractions of Myo9b used to coat the chambers. The results of this analysis (Fig. 3A) clearly show that the velocities collected for Myo9b are independent of surface motor density. Moreover, these data are well fit to a theoretical curve describing a molecular motor with a duty ratio of 1, indicating that Myo9b is strongly bound to the filament for nearly its entire hydrolytic cycle. We have shown previously (20) that the failure to exhibit a decrease in velocity at low motor densities is not because of the antibody tethering method as reductions in velocity are observed for the nonprocessive class V myosins of yeast but not for the processive motor, myosin-Va.
A second method for assaying the processivity of a motor protein requires measuring the frequency at which actin fila- 
where Avogadro's number (N o ) ϭ 6.02 ϫ 10 23 , viscosity coefficient (n) ϭ 1.00 ϫ 10 Ϫ2 g ⅐ s Ϫ1 ⅐ cm Ϫ1 , solution density () ϭ 1 g/cm 3 , and partial specific volume (v ) and hydration value (␦) were assumed to be those of average soluble proteins ϭ 0.72 cm 3 /g and 0.2, respectively. b M r calculated from amino acid composition of Myo9b heavy chain (average of the two splice forms) and four CaM light chains. ments land on a motility surface and begin to move (termed landing rate) with respect to surface motor density (22) . By analyzing the landing rate decay over lower surface densities, it is possible to estimate the number of motor/filament interactions required to produce a successful landing event (n, see Equation 2 under "Experimental Procedures"). For processive motors such as kinesin (21) and chicken myosin-Va (16), this analysis reveals that only a single motor is required to move a single microtubule/actin filament. Landing rate data as a function of Myo9b surface density (Fig. 3B ) was fit to Equation 2 (see under "Experimental Procedures") (22, 25) to estimate the number of molecules (n) required for a successful landing event. The data are well fit by the theoretical curve where n ϭ 1, indicating that one molecule of Myo9b is sufficient to bind and initiate the continuous movement of an actin filament (Fig.  3B) . Measurements of the landing rates produced by antibodytethered chick brain myosin-Va are also well fit by a curve with n ϭ 1 indicating that the mechanical properties of an antibodytethered motor molecule are unchanged (20) .
Another characteristic of processive motors like kinesin and myosin-Va is that at single motor densities the moving filament exhibits nodal pivoting, i.e. as the filament moves, it remains in focus at a single fixed point, the point of contact between a single motor and the moving filament. Nodal pivoting was observed in chambers containing low densities (3-10 g/ml anti Myo9b) of Myo9b (Fig. 4) . Moreover, at these low densities, filaments generally exhibited movements less than or equal to their length.
DISCUSSION
There are two major conclusions from this study. First, as predicted from the primary structure of Myo9b heavy chain, this is a single-headed motor consisting of a single heavy chain and associated light chains. Two independent lines of evidence, hydrodynamic determination of native molecular weight and chemical cross-linking studies support this conclusion. Because these analyses were performed using high salt extracts, it is possible that Myo9b could be part of a larger oligomeric complex under physiological conditions that could include multiple Myo9b molecules as well as other components that contribute to its functions in vivo. However, the single-headed molecule is clearly sufficient for both GAP and motor activity. Another critical question that remains unanswered with respect to subunit composition of this myosin is whether or not all the neckassociated light chains are composed of CaM or, like the class V myosins chicken myosin-Va and yeast Myo2p, consist of a mixture of CaM and other members of the EF-hand family of proteins (26, 27) . Resolution of this question will require devel- opment of techniques for purification of sufficient Myo9b for direct protein sequence analysis.
The second conclusion is that although it is single-headed, Myo9b exhibits in vitro motility properties consistent with a high duty ratio, processive motor. This is a finding consistent with our previous findings (7) that this myosin co-sediments with actin in both the absence and presence of ATP. The results showing that very low densities of motor can support movement of filaments without a density-dependent reduction in velocity indicates that this unusual actin binding behavior is not due to the presence of a second actin-binding site on the tail. Rather, like vertebrate myosin-Va, it is due to high affinity binding of the motor domain to actin in the presence of ATP.
Although the motility data presented here suggest that Myo9b is processive, it is possible that, because of the nature of the bivalent antibody tether, multiple motors sequestered within a single protein A-IgG complex could work in tandem to mimic the motile behavior of a processive motor. Arguments against the formation of random "aggregates" of Myo9b are based on the landing rate data. Previous control studies using the well characterized motor, myosin-Va, have shown that immunoadsorbed myosin-Va generates landing rate data that are well fit by Equation 2 with n ϭ 1 (20) , a result identical to previous reports (16) using direct surface adsorption techniques. Also, as argued by others (21), a good fit to Equation 2 would not be expected if the motility surface presented a mixed population of protein A-IgG complexes with one (1:1) or more (N:1) myosins bound. Moreover, the ratio of myosin tail ligand to anti-tail IgG varies across the densities sampled in these experiments and would add further complexity by varying the extent of N:1 complex formation at each IgG concentration. The good fit of both the myosin-Va control (20) and the Myo9b landing rate data to Equation 2 strongly argues that the ligand concentration we are presenting to the motility surface in these assays is below that required for significant aggregation of motor. Consequently, we feel that this assay is valid to assess the overall motile properties of tissue-obtained actin-based motors, which because of very low expression levels are not readily purified by conventional methods. Moreover, although much more detailed analysis of such motors can be obtained using in vitro expressed protein, a comparison with tissue-purified motor is essential to verify that the in vitro protein is comparable with the protein expressed in vivo.
To ensure that a Myo9b molecule does not diffuse away from its track during an advance, this myosin may invoke a mechanism similar to that originally proposed for the processive movement of the single-headed kinesin, KIF1A (28) . This motor contains a highly charged surface loop in the motor domain that weakly tethers the motor to the microtubule preventing diffusion away from the microtubule surface. The electrostatic tether allows the motor to undergo one-dimensional diffusion along its track in search of its next strong binding site (28) . The large, highly basic insertion at the actin contact site of Myo9b is an obvious candidate to participate in a similar mode of processive movement along the actin filament. Analysis of the behavior of single Myo9b motors during single steps, under unloaded and loaded conditions, will be required to determine whether a similar Brownian motor model is operative for Myo9b.
Although highly speculative, it is of interest to consider how such processive motor behavior could contribute to the presumed primary biological function of class IX myosins, downregulation of Rho-dependent signaling pathways. Its high affinity for actin may simply provide a means to localize the Rho-GAP activity, moving the motor slowly toward the ends (presumably barbed ends, but polarity of movement has yet to be determined) of filament arrays that are being remodeled during down-regulation of Rho signaling cascades. It will also be of interest to determine whether there are any regulatory interactions on the motor activity of Myo9b and various Rhosignaling elements, including Rho itself.
